Acknowledgement to Referees Acknowledgement to Referees Open access 17 November 2020 Pages: 555 - 556
How Should a Safe and Effective COVID-19 Vaccine be Allocated? Health Economists Need to be Ready to Take the Baton Laurence S. J. RoopeJohn BuckellPhilip M. Clarke Commentary Open access 03 September 2020 Pages: 557 - 561
Brentuximab Vedotin for Treating Relapsed or Refractory CD30-Positive Cutaneous T-Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal Angela StainthorpeNigel FleemanIsabel Syndikus Review Article Open access 23 March 2020 Pages: 563 - 574
Cost-Effectiveness Analyses, Costs and Resource Use, and Health-Related Quality of Life in Patients with Follicular or Marginal Zone Lymphoma: Systematic Reviews Neerav MongaJamie GarsideChristina Loefgren Systematic Review Open access 21 March 2020 Pages: 575 - 591
Economic Burden of the Out-of-Pocket Expenses for People with Multiple Sclerosis in France Olivier HeinzlefGuillaume MolinierJuliette Longin Original Research Article Open access 11 February 2020 Pages: 593 - 603
Cost Analysis of the Automated Examination of Urine with the Sysmex UN-Series™ in a Spanish Population Óscar Herráez CarreraMaría Del Monte Jarabo Bueno Original Research Article Open access 21 February 2020 Pages: 605 - 613
A Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema Management: The MULTIDEX-EMD Study Fernando de Andrés-NogalesMiguel Ángel CasadoJosé Martínez-Olmos Original Research Article Open access 25 February 2020 Pages: 615 - 624
Empirical Monetary Valuation of a Quality-Adjusted Life-Year in the Kingdom of Saudi Arabia: A Willingness-to-Pay Analysis Shouki BazarbashiEdward B. De VolMichael Iskedjian Original Research Article Open access 14 April 2020 Pages: 625 - 633
Cost-Effectiveness Analysis of Sequential Biologic Therapy with Ixekizumab Versus Secukinumab in the Treatment of Active Psoriatic Arthritis with Concomitant Moderate-to-Severe Psoriasis in the UK Bernd SchweikertChiara MalmbergSusanne Hartz Original Research Article Open access 12 March 2020 Pages: 635 - 648
Application of a Mapping Function to Estimate Utilities for Ragweed Allergy Immunotherapy Trials Katherine DickAndrew BriggsHenrik Brandi Original Research Article Open access 09 March 2020 Pages: 649 - 655
Observational Cost-Effectiveness Analysis Using Routine Data: Admission and Discharge Care Bundles for Patients with Chronic Obstructive Pulmonary Disease Padraig DixonWilliam HollingworthSarah Purdy Original Research Article Open access 25 March 2020 Pages: 657 - 667
The Budget Impact of Introducing Tildrakizumab to a United States Health Plan for Managing Moderate-to-Severe Plaque Psoriasis Justin CarricoYang ZhaoSimon Lowry Original Research Article Open access 26 March 2020 Pages: 669 - 677
A Corticosteroid-Eluting Sinus Implant Following Endoscopic Sinus Surgery for Chronic Rhinosinusitis: A UK-Based Cost-Effectiveness Analysis Mehdi JavanbakhtHesham SalehMargaret Boiano Original Research Article Open access 12 February 2020 Pages: 679 - 686
Estimation of the Incremental Cumulative Cost of HIV Compared with a Non-HIV Population Joshua P. CohenAnne BeaubrunDionne M. Hines Original Research Article Open access 26 March 2020 Pages: 687 - 696
Is Protocolised Weaning that Includes Early Extubation Onto Non-Invasive Ventilation More Cost Effective Than Protocolised Weaning Without Non-Invasive Ventilation? Findings from the Breathe Study Iftekhar KhanMandy MaredzaOn behalf of Breathe collaborators Original Research Article Open access 02 April 2020 Pages: 697 - 710